In vitro tissue models that mimic in vivo human physiology to improve drug discovery
Our latest paper in collaboration with Pfizer on the role of OCT2/MATE in creatinine clearance is accepted in JPET.
Home ›About› Our People
Dr Mike Nicholds
CEO and Co-founder
Prof Lyle Armstrong
Chief Scientific Officer and Co-founder
Dr Colin Brown
Chief Innovation Officer
Simon Berry
Finance Director
Dr Valeria Chichagova
Associate Director of iPSC Technology and Head of Retina
Dr David Hutchings
Chief Commercial Officer
Richard Strike
Operations Director
Dr Kathryn Garner
Principal Scientist, Head of Kidney Development
Dr Megan Webster
Principal Scientist, Head of Lung Development
Dr Carolina Gandara
Principal Scientist, Head of Retina Assay Development
Terry Pizzie
Non-executive Director
Dr Frank Armstrong
Non-Executive Director
Peter Dines
+44 (0)191 580 6184
© Copyright 2023 Newcells Biotech | Registered in England, company number: 09389592
Delivered with